Multiple myeloma:: Increase of the effectiveness of Velcade® (Bortezomib) through combination therapy

被引：0
|
作者：
不详
机构：
来源：
ONKOLOGIE | 2005年 / 28卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [21] Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient
    M Engelhardt
    A M S Müller
    W Maier
    R Wäsch
    Leukemia, 2005, 19 : 869 - 870
  • [22] Bortezomib therapy of multiple myeloma
    Anderson, K.
    EJC SUPPLEMENTS, 2008, 6 (12): : 15 - 16
  • [23] Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient
    Engelhardt, M
    Müller, AMS
    Maier, W
    Wäsch, R
    LEUKEMIA, 2005, 19 (05) : 869 - 870
  • [24] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    BLOOD, 2012, 120 (21)
  • [25] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [26] Velcade in multiple myeloma
    Voryakova, O. M.
    Osmanov, D. Sh
    Demina, E. A.
    Falaleeva, N. A.
    Byalik, T. E.
    Ryabukhina, Yu. E.
    Timofeepa, O. L.
    Gromova, E. G.
    Kupryshina, N. D.
    Kochergina, N., V
    TERAPEVTICHESKII ARKHIV, 2007, 79 (07) : 70 - 73
  • [27] Bortezomib (VELCADE™, formerly PS-341) as first-line therapy in patients with multiple myeloma (MM).
    Jagannath, S
    Durie, BGM
    Wolf, J
    Berliner, A
    Camacho, E
    Gabayan, E
    Irwin, D
    Lutzky, J
    McKinley, M
    Potts, P
    Noble-Kempin, S
    Davis, B
    Mazumder, A
    Crowley, J
    Jacobson, J
    Schenkein, D
    BLOOD, 2003, 102 (11) : 452A - 452A
  • [28] Combination therapy with velcade, doxil, and dexamethasone (VDD) for patients with relapsed/refractory multiple myeloma (MM).
    Jakubowiak, AJ
    Brackett, L
    Kendall, T
    Friedman, J
    Kaminski, MS
    BLOOD, 2005, 106 (11) : 378B - 378B
  • [29] Bortezomib in combination with dexamethasone for relapsed multiple myeloma
    Kropff, MH
    Bisping, G
    Wenning, D
    Volpert, S
    Tchinda, J
    Berdel, EW
    Kienast, J
    LEUKEMIA RESEARCH, 2005, 29 (05) : 587 - 590
  • [30] Cost-effectiveness of bortezomib in multiple myeloma
    Cecchi, Michele
    Caccese, Erminia
    Messori, Andrea
    Orsi, Cecilia
    Tendi, Enrico
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 485 - 486
12345